Newer Antidiabetic Drugs Linked to Improved Liver Enzymes, Steatosis

Early evidence suggests that newer diabetes drugs such as pioglitazone may improve liver enzymes and hepatic steatosis and could possibly be useful in treating non-alcoholic fatty liver disease (NAFLD), researchers say. Reuters Health Information